Prior Authorization Challenges in Healthcare: Impacts and Strategies

Diane Roston, a clinical faculty member at Dartmouth's Geisel School of Medicine and a physician at West Central Behavioral Health, highlights the challenges faced by healthcare providers due to AI-driven prior authorization delays imposed by insurers. Originally intended to promote cost-effective medication use, prior authorizations now frequently extend to generic drugs, complicating provider operations.

For instance, a patient reliant on a longstanding medication was informed by a pharmacist of new prior authorization requirements. This process involves initiating online requests and extensive administrative follow-up, leading to potential delays. Even when a drug appears on the insurer's formulary, mismatches in prescription quantities can result in denials, demanding dosage format adjustments without altering the actual dose.

Similarly, a patient on a complex, generic drug regimen for chronic conditions faced emergency care reliance due to prior authorization denials. This scenario underscores the pressure on healthcare resources and the disruptions to patient management efforts, as denials often occur under the guise of regulatory compliance requirements despite a history of successful treatment.

The process's time-intensive nature is evident. The 2024 American Medical Association Prior Authorization Physician Survey indicates that physicians and their staff manage nearly 39 authorization requests weekly, per physician. Although intended to curtail costs, University of Chicago research shows that these measures often have limited financial efficacy, potentially affecting patient adherence adversely.

Overall, the prior authorization burden is notable across healthcare systems. A study in Health Affairs reveals that drug utilization management, encompassing prior authorizations, incurs substantial costs. Many healthcare providers report that these procedures increase healthcare utilization, including emergency room visits, as emphasized by Dr. Jack Resneck, a former AMA president, who noted significant disruptions to effective treatment courses.

The extensive time spent on prior authorization negotiations detracts from patient care, echoing widespread clinician frustration. As insurance regulations evolve, fostering more efficient medication approval systems becomes increasingly essential, impacting both healthcare providers and patients alike.